Edmond de Rothschild Holding’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,288
Closed -$296K 638
2024
Q4
$296K Buy
3,288
+590
+22% +$53.1K 0.01% 374
2024
Q3
$267K Buy
2,698
+1,078
+67% +$107K ﹤0.01% 399
2024
Q2
$150K Hold
1,620
﹤0.01% 455
2024
Q1
$154K Hold
1,620
﹤0.01% 446
2023
Q4
$145K Buy
1,620
+375
+30% +$33.5K ﹤0.01% 461
2023
Q3
$90.9K Hold
1,245
﹤0.01% 496
2023
Q2
$104K Sell
1,245
-135
-10% -$11.2K ﹤0.01% 491
2023
Q1
$105K Buy
+1,380
New +$105K ﹤0.01% 505
2022
Q3
Sell
-17,000
Closed -$1.26M 861
2022
Q2
$1.26M Hold
17,000
0.03% 317
2022
Q1
$1.53M Buy
+17,000
New +$1.53M 0.03% 299
2021
Q3
Sell
-2,759
Closed -$374K 864
2021
Q2
$374K Hold
2,759
0.01% 462
2021
Q1
$374K Buy
2,759
+940
+52% +$127K 0.01% 411
2020
Q4
$256K Buy
1,819
+113
+7% +$15.9K 0.01% 412
2020
Q3
$190K Buy
1,706
+112
+7% +$12.5K 0.01% 403
2020
Q2
$178K Sell
1,594
-1,535
-49% -$171K 0.01% 385
2020
Q1
$242K Hold
3,129
0.01% 321
2019
Q4
$298K Hold
3,129
0.01% 336
2019
Q3
$239K Hold
3,129
0.01% 358
2019
Q2
$275K Buy
3,129
+300
+11% +$26.4K 0.01% 345
2019
Q1
$256K Buy
2,829
+835
+42% +$75.6K 0.01% 350
2018
Q4
$143K Sell
1,994
-2,820
-59% -$202K 0.01% 428
2018
Q3
$462K Buy
4,814
+2,820
+141% +$271K 0.01% 342
2018
Q2
$190K Hold
1,994
0.01% 479
2018
Q1
$175K Buy
1,994
+400
+25% +$35.1K 0.01% 481
2017
Q4
$135K Sell
1,594
-7,006
-81% -$593K ﹤0.01% 534
2017
Q3
$745K Buy
8,600
+734
+9% +$63.6K 0.02% 311
2017
Q2
$607K Buy
7,866
+1,223
+18% +$94.4K 0.02% 340
2017
Q1
$461K Buy
6,643
+2,143
+48% +$149K 0.01% 383
2016
Q4
$266K Hold
4,500
0.01% 445
2016
Q3
$298K Hold
4,500
0.01% 454
2016
Q2
$243K Buy
+4,500
New +$243K 0.01% 467